Correlation Between Ensysce Biosciences and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Ensysce Biosciences and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Sonnet Biotherapeutics.
Diversification Opportunities for Ensysce Biosciences and Sonnet Biotherapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ensysce and Sonnet is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Ensysce Biosciences and Sonnet Biotherapeutics
Given the investment horizon of 90 days Ensysce Biosciences is expected to under-perform the Sonnet Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ensysce Biosciences is 1.74 times less risky than Sonnet Biotherapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The Sonnet Biotherapeutics Holdings is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 160.00 in Sonnet Biotherapeutics Holdings on November 3, 2024 and sell it today you would earn a total of 5.00 from holding Sonnet Biotherapeutics Holdings or generate 3.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ensysce Biosciences vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Ensysce Biosciences |
| Sonnet Biotherapeutics |
Ensysce Biosciences and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ensysce Biosciences and Sonnet Biotherapeutics
The main advantage of trading using opposite Ensysce Biosciences and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Ensysce Biosciences vs. Zura Bio Limited | Ensysce Biosciences vs. Phio Pharmaceuticals Corp | Ensysce Biosciences vs. Sonnet Biotherapeutics Holdings | Ensysce Biosciences vs. 180 Life Sciences |
| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |